Chronic Daily Headaches

Overview

Journal Ann Indian Acad Neurol

Specialty Neurology

Date 2012 Oct 2

PMID 23024563

Citations 9

Authors

Fayyaz Ahmed

Rajsrinivas Parthasarathy

Modar Khalil

Affiliations

Soon will be listed here.

Abstract

Chronic Daily Headache is a descriptive term that includes disorders with headaches on more days than not and affects 4% of the general population. The condition has a debilitating effect on individuals and society through direct cost to healthcare and indirectly to the economy in general. To successfully manage chronic daily headache syndromes it is important to exclude secondary causes with comprehensive history and relevant investigations; identify risk factors that predict its development and recognise its sub-types to appropriately manage the condition. Chronic migraine, chronic tension-type headache, new daily persistent headache and medication overuse headache accounts for the vast majority of chronic daily headaches. The scope of this article is to review the primary headache disorders. Secondary headaches are not discussed except medication overuse headache that often accompanies primary headache disorders. The article critically reviews the literature on the current understanding of daily headache disorders focusing in particular on recent developments in the treatment of frequent headaches.

Citing Articles

Transverse Sinus Stenosis as an Underdiagnosed Cause of Chronic Headache: A Case Report.

Handal M, Tourangeau-Young R, Biglione A Cureus. 2024; 16(8):e67206.

PMID: 39295693 PMC: 11410061. DOI: 10.7759/cureus.67206.

Effectiveness of transcranial direct current stimulation (tDCS) as adjunctive treatment for chronic headache in adults with clinically stable systemic lupus erythematosus (SHADE): a randomised double-blind multiarm sham controlled clinical trial.

Estiasari R, Tiksnadi A, Tunjungsari D, Maharani K, Aninditha T, Sofyan H BMJ Open. 2023; 13(12):e076713.

PMID: 38101851 PMC: 10729133. DOI: 10.1136/bmjopen-2023-076713.

Personality in Chronic Headache: A Systematic Review with Meta-Analysis.

Bottiroli S, Renzi A, Ballante E, De Icco R, Sances G, Tanzilli A Pain Res Manag. 2023; 2023:6685372.

PMID: 37671122 PMC: 10477030. DOI: 10.1155/2023/6685372.

Nerve blocks for occipital headaches: A systematic review and meta-analysis.

Evans A, Joseph K, Samouil M, Hill D, Ibrahim M, Assi P J Anaesthesiol Clin Pharmacol. 2023; 39(2):170-180.

PMID: 37564833 PMC: 10410037. DOI: 10.4103/joacp.JOACP_62_21.

Outcomes of Surgical Treatment of Migraines: A Systematic Review & Meta-Analysis.

Evans A, Hill D, Grush A, Downer Jr M, Ibrahim M, Assi P Plast Surg (Oakv). 2023; 31(2):192-205.

PMID: 37188139 PMC: 10170648. DOI: 10.1177/22925503211036701.

References

Diener H, Bussone G, van Oene J, Lahaye M, Schwalen S, Goadsby P . Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study. Cephalalgia. 2007; 27(7):814-23. DOI: 10.1111/j.1468-2982.2007.01326.x. View

Rossi P, Jensen R, Nappi G, Allena M . A narrative review on the management of medication overuse headache: the steep road from experience to evidence. J Headache Pain. 2009; 10(6):407-17. PMC: 3476213. DOI: 10.1007/s10194-009-0159-6. View

Freitag F, Diamond S, Diamond M, Urban G . Divalproex in the long-term treatment of chronic daily headache. Headache. 2001; 41(3):271-8. DOI: 10.1046/j.1526-4610.2001.111006271.x. View

Langemark M, Olesen J, Poulsen D, Bech P . Clinical characterization of patients with chronic tension headache. Headache. 1988; 28(9):590-6. DOI: 10.1111/j.1526-4610.1988.hed2809590.x. View

Burstein R, Jakubowski M . Analgesic triptan action in an animal model of intracranial pain: a race against the development of central sensitization. Ann Neurol. 2004; 55(1):27-36. DOI: 10.1002/ana.10785. View

Goadsby P, Zanchin G, Geraud G, De Klippel N, Diaz-Insa S, Gobel H . Early vs. non-early intervention in acute migraine-'Act when Mild (AwM)'. A double-blind, placebo-controlled trial of almotriptan. Cephalalgia. 2008; 28(4):383-91. DOI: 10.1111/j.1468-2982.2008.01546.x. View

Diener H, Dodick D, Aurora S, Turkel C, DeGryse R, Lipton R . OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial. Cephalalgia. 2010; 30(7):804-14. DOI: 10.1177/0333102410364677. View

Cruccu G, Gronseth G, Alksne J, Argoff C, Brainin M, Burchiel K . AAN-EFNS guidelines on trigeminal neuralgia management. Eur J Neurol. 2008; 15(10):1013-28. DOI: 10.1111/j.1468-1331.2008.02185.x. View

Lovell B, Marmura M . New therapeutic developments in chronic migraine. Curr Opin Neurol. 2010; 23(3):254-8. DOI: 10.1097/WCO.0b013e3283396d6b. View

10.

Blumenfeld A, Varon S, Wilcox T, Buse D, Kawata A, Manack A . Disability, HRQoL and resource use among chronic and episodic migraineurs: results from the International Burden of Migraine Study (IBMS). Cephalalgia. 2010; 31(3):301-15. DOI: 10.1177/0333102410381145. View

11.

Bigal M, Lipton R . Concepts and mechanisms of migraine chronification. Headache. 2008; 48(1):7-15. DOI: 10.1111/j.1526-4610.2007.00969.x. View

12.

Bigal M, Lipton R . Excessive acute migraine medication use and migraine progression. Neurology. 2008; 71(22):1821-8. DOI: 10.1212/01.wnl.0000335946.53860.1d. View

13.

Steiner T . Lifting The Burden: the global campaign to reduce the burden of headache worldwide. J Headache Pain. 2005; 6(5):373-7. PMC: 3452068. DOI: 10.1007/s10194-005-0241-7. View

14.

Spengos K, Theleritis C, Paparrigopoulos T . Memantine and NMDA antagonism for chronic migraine: a potentially novel therapeutic approach?. Headache. 2008; 48(2):284-6. DOI: 10.1111/j.1526-4610.2007.01016.x. View

15.

Paemeleire K, Bahra A, Evers S, Matharu M, Goadsby P . Medication-overuse headache in patients with cluster headache. Neurology. 2006; 67(1):109-13. DOI: 10.1212/01.wnl.0000223332.35936.6e. View

16.

Boes C, Black D, Dodick D . Pathophysiology and management of transformed migraine and medication overuse headache. Semin Neurol. 2006; 26(2):232-41. DOI: 10.1055/s-2006-939924. View

17.

Evers S, Marziniak M . Clinical features, pathophysiology, and treatment of medication-overuse headache. Lancet Neurol. 2010; 9(4):391-401. DOI: 10.1016/S1474-4422(10)70008-9. View

18.

Katsarava Z, Jensen R . Medication-overuse headache: where are we now?. Curr Opin Neurol. 2007; 20(3):326-30. DOI: 10.1097/WCO.0b013e328136c21c. View

19.

Rossi P, Di Lorenzo C, Faroni J, Cesarino F, Nappi G . Advice alone vs. structured detoxification programmes for medication overuse headache: a prospective, randomized, open-label trial in transformed migraine patients with low medical needs. Cephalalgia. 2006; 26(9):1097-105. DOI: 10.1111/j.1468-2982.2006.01175.x. View

20.

Bordini C, Antonaci F, Stovner L, Schrader H, Sjaastad O . "Hemicrania continua": a clinical review. Headache. 1991; 31(1):20-6. DOI: 10.1111/j.1526-4610.1991.hed3101020.x. View